News - illumina | GRAIL

3/21/22

POLITICO’s West Wing Playbook: Could Biden’s FTC trip up his cancer moonshot?

1/28/22

New York Times DealBook: When Health and Antitrust Conflict

1/26/22

MLex: Illumina Will Seek to Overcome EU Antitrust Concerns Over Grail Deal, CEO Says

1/16/22

Financial Times: Illumina Says EU Probe of $8BN Grail Deal Could Hit Biotech Investment

10/8/21

WSJ: Regulatory Hurdles Block a Cancer Miracle

8/18/21

Press Release: Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test

3/30/21

Press Release: Illumina Committed to Pursuing GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test

9/21/20

Press Release: Illumina to Acquire GRAIL to Launch New Era of Cancer Detection